Skip to main content
Equibles

UBS Group AG

Position in TMO — Thermo Fisher Scientific Inc.

CIK 1610520 ZURICH, V8
Back to TMO Full portfolio

Position in TMO

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$1,205,945,748
-$140,315,347 QoQ
Shares Held
2,453,453
+5.6% QoQ
Ownership
0.660%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 37.039918840915234.ToString("F0")% Shared 0.ToString("F0")% None 62.960081159084766.ToString("F0")%

Common Shares in TMO Over Time

Shares Held

Position Value (USD)

Derivatives in TMO

reported options exposure · as of Mar 31, 2026
CallValue
$29,681,039
CallShares
60,385
PutValue
$33,129,122
PutShares
67,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

UBS Group AG holds $3,686,646,466 across 46 Diagnostics & Research names. TMO ranks #1 (32.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
This page 		2,453,453 $1,205,945,748
2 DHR
Danaher Corp /De/
 2,549,143 $483,317,510
3 WAT
Waters Corp /De/
 640,339 $190,692,952
4 IDXX
Idexx Laboratories Inc /De
 305,167 $171,470,284
5 MEDP
Medpace Holdings, Inc.
 340,433 $163,472,521
6 LH
Labcorp Holdings Inc.
 564,529 $150,621,981
7 ILMN
Illumina, Inc.
 1,162,435 $143,281,736
8 DGX
Quest Diagnostics Inc
 702,337 $137,644,004

All Filings in TMO

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $29,681,039 60,385
2026-03-31 $1,205,945,748 2,453,453
2026-03-31 $33,129,122 67,400
2025-12-31 $79,384,650 137,000
2025-12-31 $1,346,261,095 2,323,343
2025-12-31 $58,457,813 100,885
2025-09-30 $126,590,220 261,000
2025-09-30 $1,124,496,067 2,318,453
2025-09-30 $66,646,598 137,410
2025-06-30 $76,915,762 189,700
2025-06-30 $975,516,075 2,405,949
2025-06-30 $100,069,960 246,806
2025-03-31 $53,593,510 107,704
2025-03-31 $72,798,880 146,300
2025-03-31 $1,303,689,105 2,619,954
2024-12-31 $1,264,507,966 2,430,671
2024-12-31 $48,227,401 92,704
2024-12-31 $59,722,404 114,800
2024-09-30 $163,343,924 264,067
2024-09-30 $200,488,434 324,116
2024-09-30 $1,575,286,853 2,546,659
2024-06-30 $1,380,201,179 2,495,843
2024-06-30 $46,452,000 84,000
2024-06-30 $40,922,000 74,000
2024-03-31 $52,890,110 91,000
2024-03-31 $66,548,545 114,500
2024-03-31 $1,331,081,324 2,290,190
2023-12-31 $78,876,455 148,602
2023-12-31 $66,119,448 124,568
2023-12-31 $1,113,764,082 2,098,314
2023-09-30 $1,033,926,120 2,042,646
2023-09-30 $25,561,585 50,500
2023-09-30 $26,573,925 52,500
2023-06-30 $17,322,100 33,200
2023-06-30 $16,278,600 31,200
2023-06-30 $1,099,845,345 2,107,993
2023-03-31 $6,743,529 11,700
2023-03-31 $1,193,224,799 2,070,241
2023-03-31 $5,590,789 9,700
2022-12-31 $23,789,808 43,200
2022-12-31 $46,863,719 85,100
2022-12-31 $1,036,735,596 1,882,612
2022-09-30 $11,330,624 22,340
2022-09-30 $912,874,539 1,799,867
2022-09-30 $5,477,652 10,800
2022-06-30 $3,585,648 6,600
2022-06-30 $1,040,516,472 1,915,249
2022-03-31 $1,277,521,605 2,162,908
2022-03-31 $33,430,790 56,600
2022-03-31 $16,124,745 27,300

Report a Problem

Category
Description
Email (optional, for follow-up)